Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saroglitazar Magnesium in NASH (EVIDENCES VI)
NCT03863574Phase 2Completed
- Sponsor
- Zydus Therapeutics
- Start
- Jun 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saroglitazar in Nonalcoholic steatohepatitis (NASH), sponsored by Zydus Therapeutics. Started Jun 2019; status: completed.
02
Drugs
saroglitazar
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT03863574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03863574.